Gemcitabine, Bendamustine, and Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

NCT03739619 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Hodgkin Lymphoma
Refractory Hodgkin Lymphoma
Classical Hodgkin Lymphoma
Hodgkin Lymphoma

Interventions

DRUG: Bendamustine
DRUG: Gemcitabine
BIOLOGICAL: Nivolumab

Sponsor

Emory University

Collaborators

[object Object]
[object Object]
[object Object]